(Circulation. 1999;99:1666-1670.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Acute Anti-Ischemic Effect of Testosterone in Men With Coronary Artery Disease
From the Department of Cardiology, Istituto H. San Raffaele, Roma and Milano, Italy.
Correspondence to Giuseppe M.C. Rosano, MD, PhD, Department of Cardiology, Istituto H. San Raffaele, Via Elio Chianesi 33, 00144 Roma, Italy. E-mail rosanog{at}roma.hsr.it
Background—The role of testosterone on the development of coronary artery disease in men is controversial. The evidence that men have a greater incidence of coronary artery disease than women of a similar age suggests a possible causal role of testosterone. Conversely, recent studies have shown that the hormone improves endothelium-dependent relaxation of coronary arteries in men. Accordingly, the aim of the present study was to evaluate the effect of acute administration of testosterone on exercise-induced myocardial ischemia in men.
Methods and Results—After withdrawal of antianginal therapy, 14 men (mean age, 58±4 years) with coronary artery disease underwent 3 exercise tests according to the modified Bruce protocol on 3 different days (baseline and either testosterone or placebo given in a random order). The exercise tests were performed 30 minutes after administration of testosterone (2.5 mg IV in 5 minutes) or placebo. All patients showed at least 1-mm ST-segment depression during the baseline exercise test and after placebo, whereas only 10 patients had a positive exercise test after testosterone. Chest pain during exercise was reported by 12 patients during baseline and placebo exercise tests and by 8 patients after testosterone. Compared with placebo, testosterone increased time to 1-mm ST-segment depression (579±204 versus 471±210 seconds; P<0.01) and total exercise time (631±180 versus 541±204 seconds; P<0.01). Testosterone significantly increased heart rate at the onset of 1-mm ST-segment depression (135±12 versus 123±14 bpm; P<0.01) and at peak exercise (140±12 versus 132±12 bpm; P<0.01) and the rate-pressure product at the onset of 1-mm ST-segment depression (24 213±3750 versus 21 619±3542 mm Hgxbpm; P<0.05) and at peak exercise (26 746±3109 versus 22 527±5443 mm Hgxbpm; P<0.05).
Conclusions—Short-term administration of testosterone induces a beneficial effect on exercise-induced myocardial ischemia in men with coronary artery disease. This effect may be related to a direct coronary-relaxing effect.
Key Words: hormones • ischemia • heart diseases • coronary disease • exercise
This article has been cited by other articles:
 |
|
 |
|
  A. Aversa, R. Bruzziches, D. Francomano, M. Natali, and A. Lenzi Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine? Therapeutic Advances in Urology, October 1, 2009; 1(4): 179 - 197. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Mathur, C. Malkin, B. Saeed, R Muthusamy, T H. Jones, and K. Channer Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men Eur. J. Endocrinol., September 1, 2009; 161(3): 443 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yaron, Y. Greenman, J. B Rosenfeld, E. Izkhakov, R. Limor, E. Osher, G. Shenkerman, K. Tordjman, and N. Stern Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men Eur. J. Endocrinol., May 1, 2009; 160(5): 839 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mancini, E. Leone, R. Festa, G. Grande, A. Silvestrini, L. de Marinis, A. Pontecorvi, G. Maira, G. P. Littarru, and E. Meucci Effects of Testosterone on Antioxidant Systems in Male Secondary Hypogonadism J Androl, November 1, 2008; 29(6): 622 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Martorell, J. Blanco-Rivero, R. Aras-Lopez, A. Sagredo, G. Balfagon, and M. Ferrer Orchidectomy increases the formation of prostanoids and modulates their role in the acetylcholine-induced relaxation in the rat aorta Cardiovasc Res, February 1, 2008; 77(3): 590 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Foresta, N. Caretta, A. Lana, L. De Toni, A. Biagioli, A. Ferlin, and A. Garolla Reduced Number of Circulating Endothelial Progenitor Cells in Hypogonadal Men J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4599 - 4602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Liu, S. Tsang, and T. M. Wong Testosterone Is Required for Delayed Cardioprotection and Enhanced Heat Shock Protein 70 Expression Induced by Preconditioning Endocrinology, October 1, 2006; 147(10): 4569 - 4577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Blanco-Rivero, A. Sagredo, G. Balfagon, and M. Ferrer Orchidectomy increases expression and activity of Cu/Zn-superoxide dismutase, while decreasing endothelial nitric oxide bioavailability. J. Endocrinol., September 1, 2006; 190(3): 771 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Braga-Basaria, A. S. Dobs, D. C. Muller, M. A. Carducci, M. John, J. Egan, and S. Basaria Metabolic Syndrome in Men With Prostate Cancer Undergoing Long-Term Androgen-Deprivation Therapy J. Clin. Oncol., August 20, 2006; 24(24): 3979 - 3983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Shores, A. M. Matsumoto, K. L. Sloan, and D. R. Kivlahan Low Serum Testosterone and Mortality in Male Veterans. Arch Intern Med, August 14, 2006; 166(15): 1660 - 1665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hall, R. D. Jones, T. H. Jones, K. S. Channer, and C. Peers Selective Inhibition of L-Type Ca2+ Channels in A7r5 Cells by Physiological Levels of Testosterone Endocrinology, June 1, 2006; 147(6): 2675 - 2680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bernini, D. Versari, A. Moretti, A. Virdis, L. Ghiadoni, M. Bardini, C. Taurino, D. Canale, S. Taddei, and A. Salvetti Vascular Reactivity in Congenital Hypogonadal Men before and after Testosterone Replacement Therapy J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1691 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Norata, G. Tibolla, P. M. Seccomandi, A. Poletti, and A. L. Catapano Dihydrotestosterone Decreases Tumor Necrosis Factor-{alpha} and Lipopolysaccharide-Induced Inflammatory Response in Human Endothelial Cells J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 546 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hougaku, J. L. Fleg, S. S. Najjar, E. G. Lakatta, S. M. Harman, M. R. Blackman, and E. J. Metter Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E234 - E242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Meyer, B. P. McGrath, J. Cameron, D. Kotsopoulos, and H. J. Teede Vascular Dysfunction and Metabolic Parameters in Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4630 - 4635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Mendelsohn and R. H. Karas Molecular and Cellular Basis of Cardiovascular Gender Differences Science, June 10, 2005; 308(5728): 1583 - 1587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Mishra, R. K. Hermsmeyer, K. Miyagawa, P. Sarrel, B. Uchida, F. Z. Stanczyk, K. A. Burry, D. R. Illingworth, and F. J. Nordt Medroxyprogesterone Acetate and Dihydrotestosterone Induce Coronary Hyperreactivity in Intact Male Rhesus Monkeys J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3706 - 3714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A M Smith, K M English, C J Malkin, R D Jones, T H Jones, and K S Channer Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina Eur. J. Endocrinol., February 1, 2005; 152(2): 285 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Davison, J. Thipphawong, J. Blanchard, K. Liu, R. Morishige, I. Gonda, J. Okikawa, J. Adams, A. Evans, B. Otulana, et al. Pharmacokinetics and Acute Safety of Inhaled Testosterone in Postmenopausal Women J. Clin. Pharmacol., February 1, 2005; 45(2): 177 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Nieschlag, H.M. Behre, P. Bouchard, J.J. Corrales, T.H. Jones, G.K. Stalla, S.M. Webb, and F.C.W. Wu Testosterone replacement therapy: current trends and future directions Hum. Reprod. Update, September 1, 2004; 10(5): 409 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C J Malkin, P J Pugh, P D Morris, K E Kerry, R D Jones, T H Jones, and K S Channer Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life Heart, August 1, 2004; 90(8): 871 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Malkin, P. J. Pugh, R. D. Jones, D. Kapoor, K. S. Channer, and T. H. Jones The Effect of Testosterone Replacement on Endogenous Inflammatory Cytokines and Lipid Profiles in Hypogonadal Men J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3313 - 3318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Muller, A. W. van den Beld, M. L. Bots, D. E. Grobbee, S. W.J. Lamberts, and Y. T. van der Schouw Endogenous Sex Hormones and Progression of Carotid Atherosclerosis in Elderly Men Circulation, May 4, 2004; 109(17): 2074 - 2079. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Littleton-Kearney and P. D. Hurn Testosterone as a Modulator of Vascular Behavior Biol Res Nurs, April 1, 2004; 5(4): 276 - 285. [Abstract] [PDF]
|
|
|
|
|
|
A. K. Death, K. C. Y. McGrath, M. A. Sader, S. Nakhla, W. Jessup, D. J. Handelsman, and D. S. Celermajer Dihydrotestosterone Promotes Vascular Cell Adhesion Molecule-1 Expression in Male Human Endothelial Cells via a Nuclear Factor-{kappa}B-Dependent Pathway Endocrinology, April 1, 2004; 145(4): 1889 - 1897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Orshal and R. A. Khalil Gender, sex hormones, and vascular tone Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R233 - R249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Mendelsohn and G. M.C. Rosano Hormonal Regulation of Normal Vascular Tone in Males Circ. Res., December 12, 2003; 93(12): 1142 - 1145. [Full Text] [PDF]
|
|
|
|
|
|
M. Muller, Y. T. van der Schouw, J. H. H. Thijssen, and D. E. Grobbee Endogenous Sex Hormones and Cardiovascular Disease in Men J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5076 - 5086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Y. Liu, A. K. Death, and D. J. Handelsman Androgens and Cardiovascular Disease Endocr. Rev., June 1, 2003; 24(3): 313 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Pugh, T. H. Jones, and K. S. Channer Acute haemodynamic effects of testosterone in men with chronic heart failure Eur. Heart J., May 2, 2003; 24(10): 909 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C. W. Wu and A. von Eckardstein Androgens and Coronary Artery Disease Endocr. Rev., April 1, 2003; 24(2): 183 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K S Channer and T H Jones Cardiovascular effects of testosterone: implications of the "male menopause"? Heart, February 1, 2003; 89(2): 121 - 122. [Full Text] [PDF]
|
|
|
|
 |
|
 C Molinari, A Battaglia, E Grossini, D A S G Mary, C Vassanelli, and G Vacca The effect of testosterone on regional blood flow in prepubertal anaesthetized pigs J. Physiol., August 15, 2002; 543(1): 365 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zitzmann, R. Junker, A. Kamischke, and E. Nieschlag Contraceptive Steroids Influence the Hemostatic Activation State in Healthy Men J Androl, July 1, 2002; 23(4): 503 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Kenny, K. M. Prestwood, C. A. Gruman, G. Fabregas, B. Biskup, and G. Mansoor Effects of Transdermal Testosterone on Lipids and Vascular Reactivity in Older Men With Low Bioavailable Testosterone Levels J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2002; 57(7): M460 - 465. [Abstract] [Full Text]
|
|
|
|
|
|
R. K. Dubey, S. Oparil, B. Imthurn, and E. K. Jackson Sex hormones and hypertension Cardiovasc Res, February 15, 2002; 53(3): 688 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Matsumoto Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2002; 57(2): M76 - 99. [Full Text]
|
|
|
|
 |
|
 A. Q. Ding and J. N. Stallone Testosterone-induced relaxation of rat aorta is androgen structure specific and involves K+ channel activation J Appl Physiol, December 1, 2001; 91(6): 2742 - 2750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zitzmann, M. Brune, B. Kornmann, J. Gromoll, S. von Eckardstein, A. von Eckardstein, and E. Nieschlag The CAG Repeat Polymorphism in the AR Gene Affects High Density Lipoprotein Cholesterol and Arterial Vasoreactivity J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4867 - 4873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hanke, C. Lenz, B. Hess, K.-D. Spindler, and W. Weidemann Effect of Testosterone on Plaque Development and Androgen Receptor Expression in the Arterial Vessel Wall Circulation, March 13, 2001; 103(10): 1382 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Dobs, P. S. Bachorik, S. Arver, A. W. Meikle, S. W. Sanders, K. E. Caramelli, and N. A. Mazer Interrelationships among Lipoprotein Levels, Sex Hormones, Anthropometric Parameters, and Age in Hypogonadal Men Treated for 1 Year with a Permeation-Enhanced Testosterone Transdermal System J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1026 - 1033. [Abstract] [Full Text]
|
|
|
|
|
|
K. M. English, R. P. Steeds, T. H. Jones, M. J. Diver, and K. S. Channer Low-Dose Transdermal Testosterone Therapy Improves Angina Threshold in Men With Chronic Stable Angina : A Randomized, Double-Blind, Placebo-Controlled Study Circulation, October 17, 2000; 102(16): 1906 - 1911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.J. Pugh, K.M. English, T.H. Jones, and K.S. Channer Testosterone: a natural tonic for the failing heart? QJM, October 1, 2000; 93(10): 689 - 694. [Full Text] [PDF]
|
|
|
|
|
|
G.M.C. Rosano Androgens and coronary artery disease. A sex-specific effect of sex hormones? Eur. Heart J., June 1, 2000; 21(11): 868 - 871. [PDF]
|
|
|
|
|
|
K.M English, O Mandour, R.P Steeds, M.J Diver, T.H Jones, and K.S Channer Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms Eur. Heart J., June 1, 2000; 21(11): 890 - 894. [Abstract] [PDF]
|
|
|
|
|
|
C. S. Hayward, R. P. Kelly, and P. Collins The roles of gender, the menopause and hormone replacement on cardiovascular function Cardiovasc Res, April 1, 2000; 46(1): 28 - 49. [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Mark Sex Bias in Cardiovascular Care: Should Women Be Treated More Like Men? JAMA, February 2, 2000; 283(5): 659 - 661. [Full Text] [PDF]
|
|